This study examines the challenges in ensuring patients with NTRK alterations receive appropriate targeted treatments despite the effectiveness of available drugs, and emphasizes the need for improved strategies. 

Click the link below to access the abstract 

Read the abstract

NTRK positivity and conversion to appropriate personalized treatment.

Bethany Michelle Slifko, Howard L. McLeod, Wendy Moore, Inês Abrunhosa Amaral, Susanne Munksted